These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 1277227)
1. Qualitative and quantitative investigations of cyclophosphamide (NSC-26271), cyclophosphamide metabolites, and related compounds by field-desorption mass spectrometry. Schulten HR Cancer Treat Rep; 1976 Apr; 60(4):501-7. PubMed ID: 1277227 [TBL] [Abstract][Full Text] [Related]
2. Characterization of cyclophosphamide (NSC-26271) metabolites and related derivatives by field-desorption and electron-impact mass spectrometry. Przybylski M; Ringsdorf H; Voelcker G; Draeger U; Peter G; Hohorst HJ Cancer Treat Rep; 1976 Apr; 60(4):509-16. PubMed ID: 1277228 [TBL] [Abstract][Full Text] [Related]
3. Identification of metabolism pathways of anticancer drugs by high-pressure liquid chromatography in combination with field desorption mass spectrometry. Przybylski M Arzneimittelforschung; 1982; 32(9):995-1012. PubMed ID: 6756419 [TBL] [Abstract][Full Text] [Related]
4. The use of deuterated analogs in qualitative and quantitative investigations of the metabolism of cyclophosphamide (NSC-26271). Cox PJ; Farmer PB; Foster AB; Gilby ED; Jarman M Cancer Treat Rep; 1976 Apr; 60(4):483-91. PubMed ID: 1277225 [TBL] [Abstract][Full Text] [Related]
5. Mono- and diiodocyclophosphamide as possible internal standards for cyclophosphamide quantification: characterization by ion trap multi-stage mass spectrometry and effects of iodine-chlorine substitution on the fragmentation pattern. Castiglia L; Miraglia N; Pieri M; Genovese G; Simonelli A; Basilicata P; Sannolo N; Acampora A Rapid Commun Mass Spectrom; 2005; 19(13):1858-66. PubMed ID: 15945034 [TBL] [Abstract][Full Text] [Related]
6. Approaches to the pharmacokinetics of cyclophosphamide (NSC 26271): Quantitation of metabolites. Jardine I; Brundrett R; Colvin M; Fenselau C Cancer Treat Rep; 1976 Apr; 60(4):403-8. PubMed ID: 1277214 [TBL] [Abstract][Full Text] [Related]
7. Uses of field desorption mass spectrometry in the pharmaceutical industry. Brent DA J Assoc Off Anal Chem; 1976 Sep; 59(5):1006-15. PubMed ID: 965323 [TBL] [Abstract][Full Text] [Related]
8. Tandem mass spectrometric analysis of cyclophosphamide, ifosfamide and their metabolites. Liu Z; Chan KK; Wang JJ Rapid Commun Mass Spectrom; 2005; 19(18):2581-90. PubMed ID: 16106352 [TBL] [Abstract][Full Text] [Related]
9. Deactivation of cyclophosphamide (NSC-26271) metabolites by sulfhydryl compounds. Draeger J; Peter G; Hohorst HJ Cancer Treat Rep; 1976 Apr; 60(4):355-9. PubMed ID: 1277211 [TBL] [Abstract][Full Text] [Related]
10. A mass spectral study of cyclophosphamide concerning a thermally induced rearrangement reaction. Busker E; Koberstein E; Niemeyer U; Engel J; Linscheid M Biomed Environ Mass Spectrom; 1988 Feb; 15(3):163-73. PubMed ID: 3365492 [TBL] [Abstract][Full Text] [Related]
11. [Mass spectrometry of peptides]. Petit MC; Mahuzier G Ann Biol Clin (Paris); 1988; 46(5):301-11. PubMed ID: 3048156 [TBL] [Abstract][Full Text] [Related]
12. Desorption ionization mass spectrometry of synthetic porphyrins. Kurlansik L; Williams TJ; Strong JM; Anderson LW; Campana JE Biomed Mass Spectrom; 1984 Sep; 11(9):475-81. PubMed ID: 6509157 [TBL] [Abstract][Full Text] [Related]
13. Comparative pharmacologic study in vitro and in vivo with cyclophosphamide (NSC-26271), cyclophosphamide metabolites, and plain nitrogen mustard compounds. Brock N Cancer Treat Rep; 1976 Apr; 60(4):301-8. PubMed ID: 1277205 [TBL] [Abstract][Full Text] [Related]
14. Quantification of cyclophosphamide and its metabolites in urine using liquid chromatography/tandem mass spectrometry. Kasel D; Jetter A; Harlfinger S; Gebhardt W; Fuhr U Rapid Commun Mass Spectrom; 2004; 18(13):1472-8. PubMed ID: 15216508 [TBL] [Abstract][Full Text] [Related]
15. Simultaneous quantification of cyclophosphamide, 4-hydroxycyclophosphamide, N,N',N"-triethylenethiophosphoramide (thiotepa) and N,N',N"-triethylenephosphoramide (tepa) in human plasma by high-performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry. de Jonge ME; van Dam SM; Hillebrand MJ; Rosing H; Huitema AD; Rodenhuis S; Beijnen JH J Mass Spectrom; 2004 Mar; 39(3):262-71. PubMed ID: 15039933 [TBL] [Abstract][Full Text] [Related]
16. Cyclophosphamide (NSC-26271)-related phosphoramide mustards- recent advances and historical perspective. Friedman OM; Wodinsky I; Myles A Cancer Treat Rep; 1976 Apr; 60(4):337-46. PubMed ID: 1277209 [TBL] [Abstract][Full Text] [Related]
17. [Identification of bis-quaternary ammonium compounds using mild ionization mass spectrometry]. Sukhodub LF; Kosevich MV; Shelkovskií VS; Boriak OA; Volianskií IuL; Moleva VI; Chumachenko TA Antibiot Khimioter; 1990 Feb; 35(2):10-2. PubMed ID: 2337368 [TBL] [Abstract][Full Text] [Related]
18. Field desorption mass spectrometry of large multiply branched saturated hydrocarbons. Gross JH; Vékey K; Dallos A J Mass Spectrom; 2001 May; 36(5):522-8. PubMed ID: 11391808 [TBL] [Abstract][Full Text] [Related]
19. Analysis of neutral oligosaccharides for structural characterization by matrix-assisted laser desorption/ionization quadrupole ion trap time-of-flight mass spectrometry. Ojima N; Masuda K; Tanaka K; Nishimura O J Mass Spectrom; 2005 Mar; 40(3):380-8. PubMed ID: 15712371 [TBL] [Abstract][Full Text] [Related]
20. The problem of oncostatic specificity of cyclophosphamide (NSC-26271): Studies on reactions that control the alkylating and cytotoxic activity. Hohorst HJ; Draeger U; Peter G; Voelcker G Cancer Treat Rep; 1976 Apr; 60(4):309-15. PubMed ID: 1277206 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]